Investor · SAN FRANCISCO, CA

Derive Ventures GP I, LLC

Open Derive in the network graph →

Filings

10

SEC Form D

Connections

49

co-filers

Capital

$29.8M

across filings

Active

Sep 2021

to Apr 2024

Most-connected co-filers (49)

Michael Scott · SAN FRANCISCO, CA8 shared Tyler Carrico · SAN FRANCISCO, CA7 shared Jeff Stinson · Little Rock, AR7 shared Lauren G. Otsuki · San Diego, CA5 shared Jacob B. Jones · Raleigh, NC5 shared Nicole Quinn · Carlsbad, CA5 shared Gordon V. Tucker · Raleigh, NC5 shared Scott L. Glenn · Del Mar, CA4 shared Steve Howard · Singapore, U04 shared Dan Dearborn · Tampa, FL4 shared Rushika J. Fernandopulle · BOSTON, MA3 shared Dayna Quanbeck · Carlsbad, CA3 shared Jeffrey G. Brock · Raleigh, NC3 shared Scott A. Kislin · New York, NY3 shared Matthew J. Edmonds · New York, NY3 shared Ken Ehlert · Minneapolis, MN3 shared Sriram Krishnan · Palo Alto, CA3 shared Albert Zimmerli · Minneapolis, MN3 shared Carol Shen · Carlsbad, CA3 shared Alex Ross · Bay Harbor Islands, FL3 shared Lawrence Cho · Minneapolis, MN2 shared Christopher Abbott · Houston, TX2 shared Clyde Davis, Iv · Fairfax, VA2 shared Nicholas Eusepi · Houston, TX2 shared

Recent filings (10)

DERIVE VENTURES FUND I, LPApr 2024 · 8 co-filers GLO Pharma, Inc.Sep 2023 · 20 co-filers$53.0M DERIVE VENTURES FUND I, LPApr 2023 · 8 co-filers GLO Pharma, Inc.Apr 2023 · 19 co-filers$42.5M DERIVE VENTURES FUND I, LPJul 2022 · 8 co-filers GLO Pharma, Inc.Jun 2022 · 14 co-filers$33.0M GLO Pharma, Inc.Feb 2022 · 14 co-filers$23.0M MarginEdge Co.Sep 2021 · 20 co-filers$23.2M MarginEdge Co.Sep 2021 · 20 co-filers$5.0M GLO Pharma, Inc.Sep 2021 · 14 co-filers$15.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Derive in the interactive graph →